Therefore, SIGLEC5 might not only have a potential prognostic value in neuroendocrine neoplasms, but it could also be implicated in the mechanisms leading to malignant transformation and the resulting poorer clinical outcomes in these tumors. The gene discussed is SIGLEC5; the disease is neuroendocrine neoplasm.